Vivos Therapeutics

NASDAQ: VVOS ↗$0.33 USDMicro-cap (~$0.34/share, Aug 2026) MCAP

#Obstructive sleep apnea (OSA)#Snoring #Dentofacial abnormalities

Vivos Therapeutics (NASDAQ: VVOS) is a medical device and healthcare services company headquartered in Littleton, Colorado, developing and commercializing diagnostic and treatment modalities for adults with obstructive sleep apnea (OSA), snoring, and dentofacial abnormalities. Its CARE (Complete Airway Repositioning and Expansion) oral appliance technology is distributed through a network of trained dentists and sleep specialists. On August 5, 2026, the company announced a new U.S. patent broadening its CARE device portfolio and separately extended a strategic financing agreement with Streeterville Capital through August 31, 2026; the dilutive financing structure and planned rights offering drove VVOS down 26.31% that session.

Company Info

Sector:Medical devices — sleep apnea and dentofacial treatment

Headquarters:Littleton, Colorado, USA

Founded:2016

Website:vivos.com/

Clinical Development Pipeline

CARE (Complete Airway Repositioning/Expansion) oral appliance

Target: Oral airway remodeling

Obstructive sleep apnea and snoring in adults

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Vivos MMA and adjunct treatment modalities

Target: Dentofacial orthopedic intervention

OSA and dentofacial abnormalities

Preclinical

Phase 1

Phase 2

Phase 3

Approved

R. Kirk Huntsman

Chairman and Chief Executive Officer

Careers & Job Openings

See all open roles

Apply Now →